Immutep Ltd. (IMMP)
Immutep Market Cap : 23.95M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2026 | 23.95M |
| November 17, 2026 | 24.02M |
| November 16, 2026 | 25.05M |
| November 13, 2026 | 25.64M |
| November 12, 2026 | 26.93M |
| November 11, 2026 | 26.23M |
| November 10, 2026 | 25.50M |
| November 09, 2026 | 28.00M |
| November 06, 2026 | 24.61M |
| November 05, 2026 | 19.82M |
| November 04, 2026 | 21.74M |
| November 03, 2026 | 22.07M |
| November 02, 2026 | 22.62M |
| October 30, 2026 | 22.55M |
| October 29, 2026 | 24.54M |
| October 28, 2026 | 24.46M |
| October 27, 2026 | 23.21M |
| October 26, 2026 | 22.84M |
| October 23, 2026 | 23.58M |
| October 22, 2026 | 23.36M |
| October 21, 2026 | 24.17M |
| October 20, 2026 | 24.02M |
| October 19, 2026 | 23.36M |
| October 16, 2026 | 23.58M |
| October 15, 2026 | 23.65M |
| Date | Value |
|---|---|
| October 14, 2026 | 24.91M |
| October 13, 2026 | 26.31M |
| October 12, 2026 | 27.04M |
| October 09, 2026 | 26.75M |
| October 08, 2026 | 28.30M |
| October 07, 2026 | 29.92M |
| October 06, 2026 | 31.98M |
| October 05, 2026 | 31.46M |
| October 02, 2026 | 32.05M |
| October 01, 2026 | 33.45M |
| September 30, 2026 | 34.26M |
| September 29, 2026 | 34.71M |
| September 28, 2026 | 35.96M |
| September 25, 2026 | 38.83M |
| September 24, 2026 | 38.61M |
| September 23, 2026 | 39.22M |
| September 22, 2026 | 834.42M |
| September 21, 2026 | 858.59M |
| September 18, 2026 | 847.98M |
| September 17, 2026 | 934.04M |
| September 16, 2026 | 963.81M |
| September 15, 2026 | 973.54M |
| September 14, 2026 | 975.90M |
| September 11, 2026 | 1.100B |
| September 10, 2026 | 958.21M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| CSL Ltd. | 63.02B |
| Ceryvyn Therapeutics Ltd. | 4.788M |
| Propanc Biopharma, Inc. | 1.731M |
| Mesoblast Ltd. | 1.509B |
| Actinogen Medical Ltd. | 1.090B |
Market Cap Related Metrics
| PS Ratio | 2.384 |
| PEG Ratio | -0.0078 |
| Price | 3.25 |
| Earnings Yield | -224.0% |
| PEGY Ratio | -0.0078 |